| Literature DB >> 28851857 |
Xiaolong Lin1, Xi Chen1, Yan Tu1, Sa Wang2, Hui Chen1.
Abstract
BACKGROUND The purpose of this investigation was to evaluate the effect of probiotic lactobacilli on Streptococcus mutans (MS) and multispecies biofilms isolated from children with severe caries. MATERIAL AND METHODS Twenty children with active caries (DMFS ≥6) were selected as the experimental group and Streptococcus mutans (MS) were isolated from their saliva. After identification the MS strains were mixed with lactobacilli at 37°C, following which viable MS colonies were counted. At the same time dental plaques from the children were mixed with lactobacilli in vitro to form biofilms, and the population of nine common strains in the biofilms was enumerated after 24 hours of growth. RESULTS Lactobacillus casei Shirota, L. casei LC01, L. plantarum ST-III and L. paracasei LPC37 all had strong inhibitory effects on the majority the MS isolated from children with active caries, with the inhibition rate reaching approximately 70-90% (p<0.05). L. casei Shirota, L. casei LC01, L. plantarum ST-III, L. paracasei LPC37 also significantly reduced the numbers of MS, Streptococcus spp., S. sanguinis and total bacteria in mixed biofilms compared with the control group (p<0.05). CONCLUSIONS The four strains of lactobacilli were able to inhibit the growth of Streptococcus mutans and had effects on the composition of bacterial biofilms in vitro. Ingestion of probiotics may be a promising method of caries prevention.Entities:
Mesh:
Year: 2017 PMID: 28851857 PMCID: PMC5589056 DOI: 10.12659/msm.902237
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
qPCR Primers used in this study.
| Species | Sequence (5′ to 3′) | Target gene | Amplicon size(bp) |
|---|---|---|---|
| F: GTACAGTTGCTTCAGGACGTATC | 197 | ||
| R: ACGTTCGATTTCATCACGTTG | |||
| F: AGTGCCAAGACTGACGCTTT | 141 | ||
| R: GGGCTGACTGCTTCTGGAGT | |||
| F: TGCCATCAACACTCTCTTGC | 162 | ||
| R: TGACCGAAACGAACCGATAC | |||
| F: CGGATGATGCTAATCAAGTGACC | 177 | ||
| R: GTTAGCTGTTGGATTGGTTGCC | |||
| F: GTGTCATCAATTCCCAGAAAAG | 104 | ||
| R: ATTATTGGCTGATGTGGAGTC | |||
| F: AAAGGCTGCTGTTGCTGAAG | 193 | ||
| R: GGGCAAGCGATCTTTCTTTG | |||
| F: CAGTGGGTTACTTTGGCTGTC | 133 | ||
| R: CCGACCGTAGTTGTTGAAGG | |||
| F: GGAAGAGAAGACCGTAGCACAAGGA | 143 | ||
| R: GAGTAGGCGAAACGTCCATCAGGTC | |||
| F: GTCTCTTCGCCCAGATCGAG | 143 | ||
| R: GTTGGTGATGACGGTGTCG | |||
| F: CCATGAAGTCGGAATCGCTAG | 89 | ||
| R: GCTTGACGGGCGGTGT |
Inhibitory effects of L. casei Shirota on clinical isolated MS after 24 h (×108 CFU/ml, means ±SD).
| Strains | Blank control | Inhibition rate (%) | |
|---|---|---|---|
| 1 | 1.73±0.38 | 6.24±1.37 | 72.27 |
| 2 | 1.68±0.54 | 7.74±1.54 | 60.60 |
| 3 | 3.65±1.24 | 7.58±2.21 | 51.84 |
| 4 | 2.41±0.87 | 8.01±2.45 | 69.91 |
| 5 | 1.21±0.22 | 6.74±1.41 | 82.05 |
| 6 | 1.74±0.41 | 6.66±0.74 | 73.87 |
| 7 | 1.87±0.33 | 7.14±1.09 | 73.81 |
| 8 | 4.41±1.77 | 9.04±3.24 | 51.22 |
| 9 | 1.01±0.24 | 7.11±0.87 | 85.79 |
| 10 | 3.14±1.01 | 8.14±1.99 | 61.42 |
| 11 | 1.00±0.31 | 6.14±2.01 | 83.71 |
| 12 | 1.66±0.65 | 8.45±2.35 | 80.36 |
P<0.05;
P<0.01.
Inhibitory effects of L. casei LC01 on clinical isolated MS after 24 h (×108 CFU/ml, means ±SD).
| Strains | Blank control | Inhibition rate (%) | |
|---|---|---|---|
| 1 | 2.45±0.78 | 6.66±1.35 | 63.21 |
| 2 | 2.47±1.11 | 7.45±2.21 | 66.85 |
| 3 | 3.47±1.56 | 7.14±1.98 | 51.40 |
| 4 | 1.45±0.87 | 7.87±1.54 | 81.57 |
| 5 | 2.01±0.88 | 8.84±3.74 | 77.26 |
| 6 | 1.35±0.65 | 7.75±2.20 | 82.58 |
| 7 | 1.39±0.54 | 7.24±2.14 | 80.80 |
| 8 | 1.22±0.41 | 6.87±1.11 | 82.24 |
| 9 | 1.14±0.11 | 6.78±0.98 | 83.18 |
| 10 | 3.33±1.42 | 8.98±3.21 | 62.92 |
| 11 | 1.36±0.77 | 7.77±2.39 | 82.49 |
| 12 | 1.87±0.98 | 8.12±3.12 | 76.97 |
P<0.05;
P<0.01.
Inhibitory effects of L. plantarum ST-III on clinical isolated MS after 24 h (×108 CFU/ml, means ±SD).
| Strains | Blank control | Inhibition rate (%) | |
|---|---|---|---|
| 1 | 2.24±1.01 | 9.78±3.34 | 77.10 |
| 2 | 2.54±0.87 | 8.89±2.21 | 71.43 |
| 3 | 4.58±2.01 | 10.45±4.53 | 56.17 |
| 4 | 1.89±0.78 | 7.98±2.19 | 76.31 |
| 5 | 2.11±0.99 | 8.98±3.01 | 76.50 |
| 6 | 1.45±1.01 | 7.25±1.25 | 80.00 |
| 7 | 3.54±1.87 | 8.01±2.87 | 55.81 |
| 8 | 2.78±0.98 | 9.01±3.78 | 69.15 |
| 9 | 2.47±0.79 | 9.58±4.01 | 74.22 |
| 10 | 2.22±1.11 | 8.88±3.21 | 75.00 |
| 11 | 3.88±2.11 | 10.14±4.12 | 61.73 |
| 12 | 2.01±0.56 | 9.98±3.33 | 79.86 |
P<0.05;
P<0.01.
Inhibitory effects of L. paracasei LPC37 on clinical isolated MS after 24 h (×108 CFU/ml, means ±SD).
| Strains | Blank control | Inhibition rate (%) | |
|---|---|---|---|
| 1 | 1.05±0.77 | 6.98±2.10 | 84.95 |
| 2 | 2.25±1.21 | 9.27±2.26 | 75.73 |
| 3 | 1.87±0.89 | 8.45±1.21 | 77.87 |
| 4 | 2.38±1.24 | 8.45±1.39 | 71.83 |
| 5 | 4.05±2.01 | 8.12±2.22 | 50.12 |
| 6 | 1.49±0.78 | 6.98±0.79 | 78.65 |
| 7 | 1.68±0.44 | 8.84±1.25 | 80.99 |
| 8 | 3.98±1.59 | 7.58±0.88 | 47.49 |
| 9 | 2.37±1.05 | 8.47±1.58 | 72.02 |
| 10 | 2.39±1.02 | 7.87±2.01 | 69.45 |
| 11 | 1.54±0.47 | 7.87±2.09 | 80.05 |
| 12 | 2.07±1.24 | 9.01±3.21 | 77.03 |
P<0.05;
P<0.01.
Figure 1Viable Streptococcus mutans (Sm), S. spp (Spp), S. sanguinis (Ssag), S. sobrinus (Sso), S. salvarius (Sal), Porphorymona gingivalis (Pg), S. oralis (Soral), S. gordonii (Sgor) and Actinomyces naeslundii (An) in the biofilms (1) Lactobacillus casei Shirota, (2) L. casei LC01, (3) L. plantarum ST-III, (4) L. paracasei LPC37, and (C) control (S. aureus)). Data are expressed as the mean ±SD; * p<0.05; ** p<0.01.